{
  "DOI": "10.1038/ejhg.2012.281",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/ejhg.2012.281",
  "alternative-id": [
    "BFejhg2012281"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Chen",
      "given": "Yang",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Li",
      "given": "Jie",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Yu",
      "given": "Xiaoxiang",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Li",
      "given": "Shuai",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zhang",
      "given": "Xuerong",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Mo",
      "given": "Zengnan",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Hu",
      "given": "Yanling",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2013,
        1,
        9
      ]
    ],
    "date-time": "2013-01-09T13:39:24Z",
    "timestamp": 1357738764000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        18
      ]
    ],
    "date-time": "2023-05-18T17:07:09Z",
    "timestamp": 1684429629000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        10,
        5
      ]
    ],
    "date-time": "2023-10-05T13:54:03Z",
    "timestamp": 1696514043981
  },
  "is-referenced-by-count": 38,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "9",
  "issued": {
    "date-parts": [
      [
        2013,
        1,
        9
      ]
    ]
  },
  "journal-issue": {
    "issue": "9",
    "published-print": {
      "date-parts": [
        [
          2013,
          9
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2013,
            1,
            9
          ]
        ],
        "date-time": "2013-01-09T00:00:00Z",
        "timestamp": 1357689600000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/ejhg2012281.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2012281",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2012281.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "929-935",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2013,
        1,
        9
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2013,
        1,
        9
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2013,
        9
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.3322/canjclin.55.2.74",
      "author": "DM Parkin",
      "doi-asserted-by": "publisher",
      "first-page": "174",
      "journal-title": "CA Cancer J Clin",
      "key": "BFejhg2012281_CR1",
      "unstructured": "Parkin DM, Bray F, Ferlay J et al: Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 174–108.",
      "volume": "55",
      "year": "2005"
    },
    {
      "DOI": "10.3322/CA.2007.0010",
      "author": "A Jemal",
      "doi-asserted-by": "publisher",
      "first-page": "71",
      "journal-title": "CA Cancer J Clin",
      "key": "BFejhg2012281_CR2",
      "unstructured": "Jemal A, Siegel R, Ward E et al: Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71–96.",
      "volume": "58",
      "year": "2008"
    },
    {
      "DOI": "10.3322/caac.20006",
      "author": "A Jemal",
      "doi-asserted-by": "publisher",
      "first-page": "225",
      "journal-title": "CA Cancer J Clin",
      "key": "BFejhg2012281_CR3",
      "unstructured": "Jemal A, Siegel R, Ward E et al: Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225–249.",
      "volume": "59",
      "year": "2009"
    },
    {
      "DOI": "10.3322/canjclin.56.2.106",
      "author": "A Jemal",
      "doi-asserted-by": "publisher",
      "first-page": "106",
      "journal-title": "CA Cancer J Clin",
      "key": "BFejhg2012281_CR4",
      "unstructured": "Jemal A, Siegel R, Ward E et al: Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 106–130.",
      "volume": "56",
      "year": "2006"
    },
    {
      "DOI": "10.1002/ijc.2910330210",
      "author": "DG Zaridze",
      "doi-asserted-by": "publisher",
      "first-page": "223",
      "journal-title": "Int J Cancer",
      "key": "BFejhg2012281_CR5",
      "unstructured": "Zaridze DG, Boyle P, Smans M : International trends in prostatic cancer. Int J Cancer 1984; 33: 223–230.",
      "volume": "33",
      "year": "1984"
    },
    {
      "DOI": "10.1016/S0022-5347(02)80313-5",
      "author": "WH Cooner",
      "doi-asserted-by": "publisher",
      "first-page": "966",
      "journal-title": "J Urol",
      "key": "BFejhg2012281_CR6",
      "unstructured": "Cooner WH, Mosley BR, Rutherford CL et al: Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. 1990. J Urol 2002; 167: 966–973.",
      "volume": "167",
      "year": "2002"
    },
    {
      "DOI": "10.1097/01.ju.0000139993.51181.5d",
      "author": "TA Stamey",
      "doi-asserted-by": "publisher",
      "first-page": "1297",
      "journal-title": "J Urol",
      "key": "BFejhg2012281_CR7",
      "unstructured": "Stamey TA, Caldwell M, McNeal JE et al: The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? J Urol 2004; 172: 1297–1301.",
      "volume": "172",
      "year": "2004"
    },
    {
      "DOI": "10.1093/nar/28.8.e32",
      "author": "CA Eads",
      "doi-asserted-by": "publisher",
      "first-page": "E32",
      "journal-title": "Nucleic Acids Res",
      "key": "BFejhg2012281_CR8",
      "unstructured": "Eads CA, Danenberg KD, Kawakami K et al: MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000; 28: E32.",
      "volume": "28",
      "year": "2000"
    },
    {
      "DOI": "10.1007/s00428-008-0706-6",
      "author": "NY Cho",
      "doi-asserted-by": "publisher",
      "first-page": "17",
      "journal-title": "Virchows Arch",
      "key": "BFejhg2012281_CR9",
      "unstructured": "Cho NY, Kim JH, Moon KC et al: Genomic hypomethylation and CpG island hypermethylation in prostatic intraepithelial neoplasm. Virchows Arch 2009; 454: 17–23.",
      "volume": "454",
      "year": "2009"
    },
    {
      "DOI": "10.1155/2007/356742",
      "author": "VL Costa",
      "doi-asserted-by": "publisher",
      "first-page": "31",
      "journal-title": "Dis Markers",
      "key": "BFejhg2012281_CR10",
      "unstructured": "Costa VL, Henrique R, Jerónimo C : Epigenetic markers for molecular detection of prostate cancer. Dis Markers 2007; 23: 31–41.",
      "volume": "23",
      "year": "2007"
    },
    {
      "DOI": "10.1200/JCO.2005.07.009",
      "author": "MO Hoque",
      "doi-asserted-by": "publisher",
      "first-page": "6569",
      "journal-title": "J Clin Oncol",
      "key": "BFejhg2012281_CR11",
      "unstructured": "Hoque MO, Topaloglu O, Begum S et al: Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects. J Clin Oncol 2005; 23: 6569–6575.",
      "volume": "23",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.juro.2006.07.047",
      "author": "CG Rogers",
      "doi-asserted-by": "publisher",
      "first-page": "2280",
      "journal-title": "J Urol",
      "key": "BFejhg2012281_CR12",
      "unstructured": "Rogers CG, Gonzalgo ML, Yan G et al: High concordance of gene methylation in post-digital rectal examination and post-biopsy urine samples for prostate cancer detection. J Urol 2006; 176: 2280–2284.",
      "volume": "176",
      "year": "2006"
    },
    {
      "DOI": "10.1002/ijc.23196",
      "author": "M Rouprêt",
      "doi-asserted-by": "publisher",
      "first-page": "952",
      "journal-title": "Int J Cancer",
      "key": "BFejhg2012281_CR13",
      "unstructured": "Rouprêt M, Hupertan V, Catto JW et al: Promoter hypermethylation in circulating blood cells identifies prostate cancer progression. Int J Cancer 2008; 122: 952–956.",
      "volume": "122",
      "year": "2008"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-06-2467",
      "author": "M Rouprêt",
      "doi-asserted-by": "publisher",
      "first-page": "1720",
      "journal-title": "Clin Cancer Res",
      "key": "BFejhg2012281_CR14",
      "unstructured": "Rouprêt M, Hupertan V, Yates DR et al: Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage. Clin Cancer Res 2007; 13: 1720–1725.",
      "volume": "13",
      "year": "2007"
    },
    {
      "DOI": "10.1373/clinchem.2007.094912",
      "author": "T Vener",
      "doi-asserted-by": "publisher",
      "first-page": "874",
      "journal-title": "Clin Chem",
      "key": "BFejhg2012281_CR15",
      "unstructured": "Vener T, Derecho C, Baden J et al: Development of a multiplexed urine assay for prostate cancer diagnosis. Clin Chem 2008; 54: 874–882.",
      "volume": "54",
      "year": "2008"
    },
    {
      "DOI": "10.1177/1087057112444445",
      "author": "HY Yoon",
      "doi-asserted-by": "publisher",
      "first-page": "987",
      "journal-title": "J Biomol Screen",
      "key": "BFejhg2012281_CR16",
      "unstructured": "Yoon HY, Kim SK, Kim YW et al: Combined hypermethylation of APC and GSTP1 as a Molecular marker for prostate cancer: quantitative pyrosequencing analysis. J Biomol Screen 2012; 17: 987–992.",
      "volume": "17",
      "year": "2012"
    },
    {
      "DOI": "10.1002/path.1503",
      "author": "GH Kang",
      "doi-asserted-by": "publisher",
      "first-page": "233",
      "journal-title": "J Pathol",
      "key": "BFejhg2012281_CR17",
      "unstructured": "Kang GH, Lee S, Lee HJ et al: Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia. J Pathol 2004; 202: 233–240.",
      "volume": "202",
      "year": "2004"
    },
    {
      "DOI": "10.1016/j.eururo.2006.08.008",
      "author": "PJ Bastian",
      "doi-asserted-by": "publisher",
      "first-page": "665",
      "journal-title": "Eur Urol",
      "key": "BFejhg2012281_CR18",
      "unstructured": "Bastian PJ, Ellinger J, Heukamp LC et al: Prognostic value of CpG island hypermethylation at PTGS2, RAR-beta, EDNRB, and other gene loci in patients undergoing radical prostatectomy. Eur Urol 2007; 51: 665–674.",
      "volume": "51",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.urology.2007.09.056",
      "author": "J Ellinger",
      "doi-asserted-by": "publisher",
      "first-page": "161",
      "journal-title": "Urology",
      "key": "BFejhg2012281_CR19",
      "unstructured": "Ellinger J, Bastian PJ, Jurgan T et al: CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer. Urology 2008; 71: 161–167.",
      "volume": "71",
      "year": "2008"
    },
    {
      "author": "R Maruyama",
      "first-page": "514",
      "journal-title": "Clin Cancer Res",
      "key": "BFejhg2012281_CR20",
      "unstructured": "Maruyama R, Toyooka S, Toyooka KO et al: Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features. Clin Cancer Res 2002; 8: 514–519.",
      "volume": "8",
      "year": "2002"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-04-0894",
      "author": "C Jerónimo",
      "doi-asserted-by": "publisher",
      "first-page": "8472",
      "journal-title": "Clin Cancer Res",
      "key": "BFejhg2012281_CR21",
      "unstructured": "Jerónimo C, Henrique R, Hoque MO et al: A Quantitative promoter methylation profile of prostate cancer. Clin Cancer Res 2004; 10: 8472–8478.",
      "volume": "10",
      "year": "2004"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-04-0108",
      "author": "Y Tokumaru",
      "doi-asserted-by": "publisher",
      "first-page": "5518",
      "journal-title": "Clin Cancer Res",
      "key": "BFejhg2012281_CR22",
      "unstructured": "Tokumaru Y, Harden SV, Sun DI et al: Optimal use of a panel of methylation markers with GSTP1 hypermethylation in the diagnosis of prostate adenocarcinoma. Clin Cancer Res 2004; 10: 5518–5522.",
      "volume": "10",
      "year": "2004"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-04-1832",
      "author": "PJ Bastian",
      "doi-asserted-by": "publisher",
      "first-page": "4097",
      "journal-title": "Clin Cancer Res",
      "key": "BFejhg2012281_CR23",
      "unstructured": "Bastian PJ, Ellinger J, Wellmann A et al: Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci. Clin Cancer Res 2005; 11: 4097–4106.",
      "volume": "11",
      "year": "2005"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-05-0658",
      "author": "H Enokida",
      "doi-asserted-by": "publisher",
      "first-page": "6582",
      "journal-title": "Clin Cancer Res",
      "key": "BFejhg2012281_CR24",
      "unstructured": "Enokida H, Shiina H, Urakami S et al: Multigene methylation analysis for detection and staging of prostate cancer. Clin Cancer Res 2005; 11: 6582–6588.",
      "volume": "11",
      "year": "2005"
    },
    {
      "DOI": "10.1158/1541-7786.MCR-05-0113",
      "author": "R Henrique",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Mol Cancer Res",
      "key": "BFejhg2012281_CR25",
      "unstructured": "Henrique R, Jerónimo C, Teixeira MR et al: Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: clues for clonal progression in prostate carcinogenesis. Mol Cancer Res 2006; 4: 1–8.",
      "volume": "4",
      "year": "2006"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-03-3972",
      "author": "S Yegnasubramanian",
      "doi-asserted-by": "publisher",
      "first-page": "1975",
      "journal-title": "Cancer Res",
      "key": "BFejhg2012281_CR26",
      "unstructured": "Yegnasubramanian S, Kowalski J, Gonzalgo ML et al: Hypermethylation of CpG islands in primary and metastatic human prostate cancer. Cancer Res 2004; 64: 1975–1986.",
      "volume": "64",
      "year": "2004"
    },
    {
      "DOI": "10.1002/path.2106",
      "author": "NY Cho",
      "doi-asserted-by": "publisher",
      "first-page": "269",
      "journal-title": "J Pathol",
      "key": "BFejhg2012281_CR27",
      "unstructured": "Cho NY, Kim BH, Choi M et al: Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features. J Pathol 2007; 211: 269–277.",
      "volume": "211",
      "year": "2007"
    },
    {
      "DOI": "10.1155/2011/157829",
      "author": "N Vasiljević",
      "doi-asserted-by": "publisher",
      "first-page": "151",
      "journal-title": "Dis Markers",
      "key": "BFejhg2012281_CR28",
      "unstructured": "Vasiljević N, Wu K, Brentnall AR et al: Absolute quantitation of DNA methylation of 28 candidate genes in prostate cancer using pyrosequencing. Dis Markers 2011; 30: 151–161.",
      "volume": "30",
      "year": "2011"
    },
    {
      "DOI": "10.1111/j.1464-410X.2011.10718.x",
      "author": "BJ Trock",
      "doi-asserted-by": "publisher",
      "first-page": "56",
      "journal-title": "BJU Int",
      "key": "BFejhg2012281_CR29",
      "unstructured": "Trock BJ, Brotzman MJ, Mangold LA et al: Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies. BJU Int 2012; 110: 56–62.",
      "volume": "110",
      "year": "2012"
    },
    {
      "DOI": "10.7326/0003-4819-127-9-199711010-00008",
      "author": "J Lau",
      "doi-asserted-by": "publisher",
      "first-page": "820",
      "journal-title": "Ann Intern Med",
      "key": "BFejhg2012281_CR30",
      "unstructured": "Lau J, Ioannidis JP, Schmid CH : Quantitative synthesis in systematic reviews. Ann Intern Med 1997; 127: 820–826.",
      "volume": "127",
      "year": "1997"
    },
    {
      "DOI": "10.1177/0272989X9301300313",
      "author": "AS Midgette",
      "doi-asserted-by": "publisher",
      "first-page": "253",
      "journal-title": "Med Decis Making",
      "key": "BFejhg2012281_CR31",
      "unstructured": "Midgette AS, Stukel TA, Littenberg B : A meta-analytic method for summarizing diagnostic test performances: receiver-operating-characteristic-summary point estimates. Med Decis Making 1993; 13: 253–257.",
      "volume": "13",
      "year": "1993"
    },
    {
      "DOI": "10.1038/bjc.2011.143",
      "author": "T Wu",
      "doi-asserted-by": "publisher",
      "first-page": "65",
      "journal-title": "Br J Cancer",
      "key": "BFejhg2012281_CR32",
      "unstructured": "Wu T, Giovannucci E, Welge J et al: Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis. Br J Cancer 2011; 105: 65–73.",
      "volume": "105",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s00432-010-0941-5",
      "author": "H Schwarzenbach",
      "doi-asserted-by": "publisher",
      "first-page": "811",
      "journal-title": "J Cancer Res Clin Oncol",
      "key": "BFejhg2012281_CR33",
      "unstructured": "Schwarzenbach H, Chun FK, Isbarn H et al: Genomic profiling of cell-free DNA in blood and bone marrow of prostate cancer patients. J Cancer Res Clin Oncol 2011; 137: 811–819.",
      "volume": "137",
      "year": "2011"
    },
    {
      "DOI": "10.1111/j.1442-2042.2010.02502.x",
      "author": "T Okegawa",
      "doi-asserted-by": "publisher",
      "first-page": "466",
      "journal-title": "Int J Urol",
      "key": "BFejhg2012281_CR34",
      "unstructured": "Okegawa T, Nutahara K, Higashihara E : Association of circulating tumor cells with tumor-related methylated DNA in patients with hormone-refractory prostate cancer. Int J Urol 2010; 17: 466–475.",
      "volume": "17",
      "year": "2010"
    },
    {
      "DOI": "10.1111/j.1464-410X.2009.08696.x",
      "author": "V Phé",
      "doi-asserted-by": "publisher",
      "first-page": "896",
      "journal-title": "BJU Int",
      "key": "BFejhg2012281_CR35",
      "unstructured": "Phé V, Cussenot O, Rouprêt M : Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract. BJU Int 2009; 104: 896–901.",
      "volume": "104",
      "year": "2009"
    },
    {
      "DOI": "10.1111/j.1464-410X.2009.09167.x",
      "author": "V Phé",
      "doi-asserted-by": "publisher",
      "first-page": "1364",
      "journal-title": "BJU Int",
      "key": "BFejhg2012281_CR36",
      "unstructured": "Phé V, Cussenot O, Rouprêt M : Methylated genes as potential biomarkers in prostate cancer. BJU Int 2010; 105: 1364–1370.",
      "volume": "105",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.juro.2009.05.003",
      "author": "J Baden",
      "doi-asserted-by": "publisher",
      "first-page": "1186",
      "journal-title": "J Urol",
      "key": "BFejhg2012281_CR37",
      "unstructured": "Baden J, Green G, Painter J et al: Multicenter evaluation of an investigational prostate cancer methylation assay. J Urol 2009; 182: 1186–1193.",
      "volume": "182",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.juro.2011.06.052",
      "author": "J Baden",
      "doi-asserted-by": "publisher",
      "first-page": "2101",
      "journal-title": "J Urol",
      "key": "BFejhg2012281_CR38",
      "unstructured": "Baden J, Adams S, Astacio T et al: Predicting prostate biopsy result in men with prostate specific antigen 2.0 to 10.0 ng/ml using an investigational prostate cancer methylation assay. J Urol 2011; 186: 2101–2106.",
      "volume": "186",
      "year": "2011"
    },
    {
      "DOI": "10.1038/sj.bjc.6602030",
      "author": "AR Florl",
      "doi-asserted-by": "publisher",
      "first-page": "985",
      "journal-title": "Br J Cancer",
      "key": "BFejhg2012281_CR39",
      "unstructured": "Florl AR, Steinhoff C, Müller M et al: Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylation. Br J Cancer 2004; 91: 985–994.",
      "volume": "91",
      "year": "2004"
    },
    {
      "DOI": "10.1186/1471-2490-12-16",
      "author": "L Van Neste",
      "doi-asserted-by": "publisher",
      "first-page": "16",
      "journal-title": "BMC Urol",
      "key": "BFejhg2012281_CR40",
      "unstructured": "Van Neste L, Bigley J, Toll A et al: A tissue biopsy-based epigenetic multiplex PCR assay for prostate cancer detection. BMC Urol 2012; 12: 16.",
      "volume": "12",
      "year": "2012"
    },
    {
      "author": "GD Stewart",
      "first-page": "04906",
      "journal-title": "J Urol",
      "key": "BFejhg2012281_CR41",
      "unstructured": "Stewart GD, Van Neste L, Delvenne P et al: Clinical utility of an epigenetic assay to detect occult prostate cancer in histopathologically negative biopsies: results of the MATLOC Study. J Urol 2012; S0022-5347: 04906–3.",
      "volume": "S0022-5347",
      "year": "2012"
    },
    {
      "DOI": "10.1200/JCO.2008.18.2485",
      "author": "L Richiardi",
      "doi-asserted-by": "publisher",
      "first-page": "3161",
      "journal-title": "J Clin Oncol",
      "key": "BFejhg2012281_CR42",
      "unstructured": "Richiardi L, Fiano V, Vizzini L et al: Promoter methylation in APC, RUNX3, and GSTP1 and mortality in prostate cancer patients. J Clin Oncol 2009; 27: 3161–3168.",
      "volume": "27",
      "year": "2009"
    },
    {
      "author": "A Padar",
      "first-page": "4730",
      "journal-title": "Clin Cancer Res",
      "key": "BFejhg2012281_CR43",
      "unstructured": "Padar A, Sathyanarayana UG, Suzuki M et al: Inactivation of cyclin D2 gene in prostate cancers by aberrant promoter methylation. Clin Cancer Res 2003; 9: 4730–4734.",
      "volume": "9",
      "year": "2003"
    },
    {
      "DOI": "10.4161/epi.5.4.11749",
      "author": "VL Costa",
      "doi-asserted-by": "publisher",
      "first-page": "343",
      "journal-title": "Epigenetics",
      "key": "BFejhg2012281_CR44",
      "unstructured": "Costa VL, Henrique R, Ribeiro FR et al: Epigenetic regulation of Wnt signaling pathway in urological cancer. Epigenetics 2010; 5: 343–351.",
      "volume": "5",
      "year": "2010"
    },
    {
      "DOI": "10.1002/ijc.25908",
      "author": "L Liu",
      "doi-asserted-by": "publisher",
      "first-page": "2454",
      "journal-title": "Int J Cancer",
      "key": "BFejhg2012281_CR45",
      "unstructured": "Liu L, Kron KJ, Pethe VV et al: Association of tissue promoter methylation levels of APC, TGFβ2, HOXD3 and RASSF1A with prostate cancer progression. Int J Cancer 2011; 129: 2454–2462.",
      "volume": "129",
      "year": "2011"
    },
    {
      "DOI": "10.1159/000318017",
      "author": "I Steiner",
      "doi-asserted-by": "publisher",
      "first-page": "260",
      "journal-title": "Pathobiology",
      "key": "BFejhg2012281_CR46",
      "unstructured": "Steiner I, Jung K, Schatz P et al: Gene promoter methylation and its potential relevance in early prostate cancer diagnosis. Pathobiology 2010; 77: 260–266.",
      "volume": "77",
      "year": "2010"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-09-0068",
      "author": "DA Troyer",
      "doi-asserted-by": "publisher",
      "first-page": "2717",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "BFejhg2012281_CR47",
      "unstructured": "Troyer DA, Lucia MS, de Bruïne AP et al: Prostate cancer detected by methylated gene markers in histopathologically cancer-negative tissues from men with subsequent positive biopsies. Cancer Epidemiol Biomarkers Prev 2009; 18: 2717–2722.",
      "volume": "18",
      "year": "2009"
    },
    {
      "DOI": "10.1007/s10552-012-0032-9",
      "author": "A Gillio-Tos",
      "doi-asserted-by": "publisher",
      "first-page": "1549",
      "journal-title": "Cancer Causes Control",
      "key": "BFejhg2012281_CR48",
      "unstructured": "Gillio-Tos A, Fiano V, Zugna D et al: DNA methyltransferase 3b (DNMT3b), tumor tissue DNA methylation, Gleason score, and prostate cancer mortality: investigating causal relationships. Cancer Causes Control 2012; 23: 1549–1555.",
      "volume": "23",
      "year": "2012"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-05-1183",
      "author": "E Rosenbaum",
      "doi-asserted-by": "publisher",
      "first-page": "8321",
      "journal-title": "Clin Cancer Res",
      "key": "BFejhg2012281_CR49",
      "unstructured": "Rosenbaum E, Hoque MO, Cohen Y et al: Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy. Clin Cancer Res 2005; 11: 8321–8325.",
      "volume": "11",
      "year": "2005"
    },
    {
      "DOI": "10.1089/dna.2011.1311",
      "author": "L Delgado-Cruzata",
      "doi-asserted-by": "publisher",
      "first-page": "187",
      "journal-title": "DNA Cell Biol",
      "key": "BFejhg2012281_CR50",
      "unstructured": "Delgado-Cruzata L, Hruby GW, Gonzalez K et al: DNA methylation changes correlate with Gleason score and tumor stage in prostate cancer. DNA Cell Biol 2012; 31: 187–192.",
      "volume": "31",
      "year": "2012"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-07-1042",
      "author": "R Henrique",
      "doi-asserted-by": "publisher",
      "first-page": "6122",
      "journal-title": "Clin Cancer Res",
      "key": "BFejhg2012281_CR51",
      "unstructured": "Henrique R, Ribeiro FR, Fonseca D et al: High promoter methylation levels of APC predict poor prognosis in sextant biopsies from prostate cancer patients. Clin Cancer Res 2007; 13: 6122–6129.",
      "volume": "13",
      "year": "2007"
    },
    {
      "DOI": "10.1373/clinchem.2008.108845",
      "author": "JP Clark",
      "doi-asserted-by": "publisher",
      "first-page": "2007",
      "journal-title": "Clin Chem",
      "key": "BFejhg2012281_CR52",
      "unstructured": "Clark JP, Munson KW, Gu JW et al: Performance of a single assay for both type III and type VI TMPRSS2:ERG fusions in noninvasive prediction of prostate biopsy outcome. Clin Chem 2008; 54: 2007–2017.",
      "volume": "54",
      "year": "2008"
    },
    {
      "DOI": "10.4161/cbt.5.8.2885",
      "author": "A Neuhausen",
      "doi-asserted-by": "publisher",
      "first-page": "993",
      "journal-title": "Cancer Biol Ther",
      "key": "BFejhg2012281_CR53",
      "unstructured": "Neuhausen A, Florl AR, Grimm MO et al: DNA methylation alterations in urothelial carcinoma. Cancer Biol Ther 2006; 5: 993–1001.",
      "volume": "5",
      "year": "2006"
    },
    {
      "DOI": "10.1056/NEJM199410133311507",
      "author": "WJ Catalona",
      "doi-asserted-by": "publisher",
      "first-page": "996",
      "journal-title": "N Engl J Med",
      "key": "BFejhg2012281_CR54",
      "unstructured": "Catalona WJ : Management of cancer of the prostate. N Engl J Med 1994; 331: 996–1004.",
      "volume": "331",
      "year": "1994"
    },
    {
      "DOI": "10.4161/epi.19463",
      "author": "SE Mahoney",
      "doi-asserted-by": "publisher",
      "first-page": "400",
      "journal-title": "Epigenetics",
      "key": "BFejhg2012281_CR55",
      "unstructured": "Mahoney SE, Yao Z, Keyes CC et al: Genome-wide DNA methylation studies suggest distinct DNA methylation patterns in pediatric embryonal and alveolar rhabdomyosarcomas. Epigenetics 2012; 7: 400–408.",
      "volume": "7",
      "year": "2012"
    }
  ],
  "reference-count": 55,
  "references-count": 55,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/ejhg2012281"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "APC gene hypermethylation and prostate cancer: a systematic review and meta-analysis"
  ],
  "type": "journal-article",
  "volume": "21"
}